Sleep Breathing Disorders (SBD), especially Obstructive Sleep Apnea Syndromes (OSAS) lead to a lot of physical problems like hypertension and arrhythmias and even to neuropsychiatric consequences like Brain atrophy, Depression, Anxiety and Insomnia. Apart from a multitude of physical complaints, OSAS patients suffer from Excessive Daytime Sleepiness (EDS), reduced sustained attention, limited memory processes and cognitive functions and reduced Quality of Life (QoL). The apnea related neuropsychiatric diseases could be associated with conditions interfering with the mechanisms of mental and sensory-motor plasticity. In our study we used neuropsychological and neuropsychiatric methods in different patient groups in a sleep laboratory. Over the past five years we have tested more than 2000 patients. During admission to the clinic, all patients were selected according to their clinical diagnosis (ICD-10) and all patients were examined neurologically, neuro-psychologically and psychiatrically. All test persons must not suffer from any severe psychiatric disorders. The study was carried out involving all groups of randomly selected patients with OSAS on a number of neuropsychiatric parameters. In this context we analyzed e.g. (1) excessive daytime sleepiness by Epworth Sleepiness Scale (ESS) and Reading Test (2) attention deficits by vigilance test Carda and Clock Test and by sustained attention test Carsim, (3) memory dysfunction by Number Connection Test (ZVT) and Benton Test, (4) psychiatric consequences (e.g. depression by BDI, anxiety by HADS) and (5) quality of life by different questionnaires (SWLS, MLDL, FOSQ, SAQLI). Testing of neuropsychiatric diseases, memory processes and quality of life revealed a highly significant difference between healthy persons and OSAS patients ( p < 0.05). Examination of specific domains of neuropsychiatric diseases, memory processes and quality of life showed significant differences in patients with OSAS. In all dimensions of neuropsychiatric diseases, memory processes and quality of life, untreated OSAS patients had inferior scores to those who had undergone therapy. After more than 6 weeks of nCPAP therapy, the neuropsychiatric diseases of the OSAS patients, memory processes and quality of life improved to a significant degree ( p < 0.05). Analysis of the degree of severity showed for OSAS that on the whole, there is a significant difference concerning neuropsychiatric diseases, memory processes and quality of life. The study revealed that patients with OSAS show neuropsychiatric problems and deficits concerning their vigilance achievements, their memory processes and their quality of life. The improvement of vigilance achievements and memory processes show a lower driving fitness (traffic safety) in untreated patients and increasing traffic safety in treated patients. In summary, based on our results, it is to be said that although a continuous nCPAP therapy improves the OSAS symptoms; neuropsychiatric consequences, memory processes and the quality of life require longer-term recovery.